Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and ProsciaÂź, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.
Stratipath secures its position on the esteemed startup list for the second consecutive year.
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and ProsciaÂź, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.
Webinar with the Swedish Breast Cancer association
Stratipath co-founder and Chief Medical Officer Johan Hartman, was participating in a webinar hosted by the Swedish Breast Cancer Association (Bröstcancerförbundet) to discuss the impact of AI in breast cancer care.
Stratipath co-founders, Mattias Rantalainen and Johan Hartman are receiving the prestigious Karolinska Institutetâs award for innovation and utilisation.
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and ProsciaÂź, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.
âAI can be a game-changerâ An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine âMĂ„ Braâ
More people are living longer with breast cancer â AI can be a game-changer.As October marks Breast Cancer Awareness Month, “MĂ„ Bra,” the Swedish wellness magazine, initiates this significant month with an exclusive interview featuring Stratipath co-founder Johan Hartman. The interview delves into topics such as groundbreaking treatments, precision medicine, and the game-changing potential of AI-powered […]
Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm.
Excited to share that Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm, contributing to the evolution of Sweden’s medical industry. Thanks to EU Startup News for the acknowledgement! â This startup is working diligently to enhance treatment decisions and outcomes in cancer care. Their work exemplifies the transformative impact of technological […]
Stratipath co-founder Mattias Rantalainen is featured in this article by Healthcareineurope.com
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and ProsciaÂź, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.
Professor Jonas Bergh, will be leading our scientific advisory board
Stratipath is happy to announce that one of the most prominent breast oncologists, Professor Jonas Bergh, will be leading the companyâs scientific advisory board. As Stratipath is entering the clinical phase with its first-in-class, CE-IVD solution for AI-driven risk profiling, Stratipath breast and at the same time ramping up the research and development efforts for future solutions, the scientific advisory board will play a crucial role in the companyâs development.
Stratipath on prestigious startup-list
Stratipath is listed in tech magazine Ny Teknikâs 33-list, which selects the most promising Swedish start-ups each year.
âThe path from academic research to precision diagnostics in routine health careâ Stratipath co-founder is writing an article about Stratipath and the research behind in âOncology Swedenâ. (Swedish only)
Read the article (Swedish only)